Cromoglycate markedly activates ascorbate-ADP initiated lipid peroxidation in washed rat liver microsomes.
W e have been studying a novel, reductant-dependent lipid antioxidant system in r a t liver preparations. In a preceding communication we show that this is triggered by nucleoside triphosphates, possibly via a G-protein mechanism. I t is selectively antagonised by cromoglycate, a nucleoside diphosphokinase inhibitor.
Lipid peroxidation (LPO) was initiated non-enzymatically with 0.2 mM ascorbate in the presence of 1 mM nucleoside triphosphates or ADP and was assayed by measuring t h e formation of thiobarbituric reactive substances (TBARS) as in I 1 1.
As a standard control, to measure the uninhibited LPO-rate, microsomes were incubated with ascorbate/ADP. W e were suprised to observe that inclusion of 10 mM sodium cromoglycate in these incubations enhanced this control r a t e more than 3-fold from 18 f 7 ( 12 ) to 60 f 7 ( 4 ) nmol TBARS/mg protein/30 min.
There are a number of ways in which cromoglycate might activate the ascorbate/ADP control and not all of them have yet been explored. An interesting possibility, however, is the following. Suppose that microsomal adenylate kinase I 2 1 were t o convert significant amounts of ADP to AMP + ATP.
In the absence of cromoglycate this ATP might be expected t o trigger the lipid antioxidant system under investigation. However, with cromoglycate present this would not be possible ( Eqn. 1 ). If this hypothetical mechanism applies, then i? preparations containing the nucleotide stimulated lipid antioxidant system, this classic LPO control would not yield a true "basal rate" for peroxidation.
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Eqn. 1 I t should be possible to test the mechanism above by including in incubations the specific adenylate kinase inhibitor, PI ,P5-di(adenosine-5') pentaphosphate I 3 1. If this acts without confounding effects, it should itself activate the ADP/ascorbate control by preventing the conversion of ADP to ATP and should also prevent cromoglycate from activating the control further. Should this mechanism prove to be applicable, its utility might be for probing the reductant-specificity of the nucleotide stimulated lipid antioxidant mechanism. Nucleotides alone appear completely inert with the system which apparently has an obligate requirement for reductant. Though i t has been possible studying LPO initiated by cumene hydroperoxide to show that t h e system can employ ascorbate to inhibit LPO. I t is impossible using this approach t o assess whether it can also employ, for example, NADPH, NADH or CSH as reductants. The reasons a r e as follows :-by reducing cytochrome P450, the pyridine nucleotides themselves thereby directly antagonize LPO initiation by cumene hydroperoxide [ 4, 5, Devereux et al, unpublished 1. With GSH, of course, the initiator will be conjugated via microsomal transferases and the peroxidase, again inhibiting LPO without t h e intervention of t h e nucleotide-activated system. Attempts t o use different initiators such as lipoxygenases have yielded vanishingly low rates of microsomal LPO.
In conclusion, sodium cromoglycate, which selectively strongly antagonises the stimulation of a novel lipid antioxidant mechanism in microsomes by ATP, UTP and CTP but not by GTP, also activates the ADP/ascorbate control r a t e of LPO. A potential mechanism is outlined by which this activation of controls may occur. The utility of this potential mechanism, if verified, for further probing the detailed action of t h e lipid antioxidant system itself, is discussed.
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